148 related articles for article (PubMed ID: 3551846)
1. [Second-generation cisplatin analogs].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1043-50. PubMed ID: 3551846
[TBL] [Abstract][Full Text] [Related]
2. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
[TBL] [Abstract][Full Text] [Related]
3. [Development of carboplatin].
Tsukagoshi S
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1949-58. PubMed ID: 2203318
[TBL] [Abstract][Full Text] [Related]
4. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
5. [Development of platinum analogues for the treatment of lung cancer].
Nakai Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2157-62. PubMed ID: 1332625
[TBL] [Abstract][Full Text] [Related]
6. [Current status of CDDP analogs in gynecologic malignancies].
Yakushiji M; Nishimura H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1393-8. PubMed ID: 2658828
[TBL] [Abstract][Full Text] [Related]
7. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.
Al-Sarraf M; Metch B; Kish J; Ensley J; Rinehart JJ; Schuller DE; Coltman CA
Cancer Treat Rep; 1987; 71(7-8):723-6. PubMed ID: 3300967
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogue.
Winograd B; Vermorken JB; ten Bokkel Huinink WW; Simonetti G; Gall HE; Knobf MK; van der Vijgh WJ; McVie JG; Pinedo HM
Cancer Res; 1986 Apr; 46(4 Pt 2):2148-51. PubMed ID: 3948186
[TBL] [Abstract][Full Text] [Related]
9. [Experimental evaluation of cisplatin analogous in urogenital cancer].
Machida T; Akasaka Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
[TBL] [Abstract][Full Text] [Related]
11. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate.
Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y
Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753
[TBL] [Abstract][Full Text] [Related]
12. [Organoplatinum compounds. 1987 update].
Extra JM; Espie M; Calvo F; Marty M
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):123-30. PubMed ID: 3290835
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin versus cisplatin in ovarian cancer.
Alberts DS
Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
[TBL] [Abstract][Full Text] [Related]
15. [Present status of cisplatin (CDDP) analogues in Japan].
Majima H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1373-8. PubMed ID: 2658825
[TBL] [Abstract][Full Text] [Related]
16. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
17. Clinical development of iproplatin (CHIP).
Creaven PJ; Pendyala L; Madajewicz S
Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
Cancer Treat Rep; 1985 Nov; 69(11):1305-7. PubMed ID: 3912041
[TBL] [Abstract][Full Text] [Related]
19. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
20. Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.
Anderson H; Wagstaff J; Crowther D; Swindell R; Lind MJ; McGregor J; Timms MS; Brown D; Palmer P
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1471-9. PubMed ID: 3053207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
